Photostimulated Anticancer Activity of Mitochondria Localized Rhenium(I) Tricarbonyl Complexes Bearing 1<i>H</i>‐imidazo[4,5‐<i>f</i>][1,10]phenanthroline Ligands Against MDA‐MB‐231 Cancer Cells
We have introduced Re(I) tricarbonyl complexes (ReL1 - ReL6) [Re(CO)<sub>3</sub>(N^N)Cl] where N^N=extensive π conjugated imidazo-[4,5-f][1,10]-phenanthroline derivatives that helps in strong DNA intercalation, enhanced photophysical behavior, increase the <sup>3</sup>π-π* character of T<sub>1</sub> state for PDT and high value of lipophilicity for cell membrane penetration. These complexes exhibited prominent intraligand/ligand-centered (π-π*/<sup>1</sup>LC) absorption bands at λ 260-350 nm and relatively weak metal-to-ligand charge-transfer (<sup>1</sup>MLCT) bands within the λ 350-550 nm range. Among the six synthesized complexes, [(CO)<sub>3</sub>Re<sup>I</sup>Cl(K<sup>2</sup>-N,N-2-(4-(1-benzyl-1H-tetrazol-5-yl)phenyl)-1H-imidazo[4,5-f][1,10]phenanthroline] (ReL6) exhibited outstanding potency (IC<sub>50</sub>~6 μM, PI>9) under yellow light irradiation compared to dark conditions. Importantly, extremely lipophilic complex ReL6 showed effective penetration through the cell membrane and localized primarily in mitochondria (Pearson's correlation coefficient, PCC=0.918) of MDA-MB-231 cells. Complex ReL6 exhibited more than 9 times higher photo-toxicity in normoxic and hypoxic environment of tumor by inducing <sup>1</sup>O<sub>2</sub> generation (type II PDT), radical generation triggered by NADH oxidation (type I PDT). This complex is a promising candidate for TNBC treatment in hypoxic tumors, with efficacy comparable to photofrin and have demonstrated CO release ability under UV light irradiation.
Authors
- Priyankar Paira (ORCID: https://orcid.org/0000-0003-1698-4895)
- Binoy Kar (ORCID: https://orcid.org/0000-0002-2059-6900)
Institutions
- Vellore Institute of Technology University (IN)
Publication Details
- Journal
- Chemistry - A European Journal
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1002/chem.202401720
- Citations
- 7
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 1.29